Physician profile
Charles Joseph Miller
NPI 1013980036
$3,554.99
in general payments reported to CMS, 2019-2025
10 companies · $644 in 2025
The $644 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,242 · 2021: $111 · 2022: $18.65 · 2023: $434 · 2024: $106 · 2025: $644.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $584 · Food and Beverage: $560 · Education: $39.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $584.43 |
| Food and Beverage | $559.70 |
| Education | $39.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synaptive Medical INC. | $2,227.19 | 2019 | |
| Globus Medical, INC. | $741.79 | 2023-2025 | Excelsius Gps, Excelsiusgps Robotic Navigation System, Excelsius Deformity |
| Astrazeneca Pharmaceuticals Lp | $281.00 | 2023-2024 | Andexxa |
| Stryker Corporation | $97.34 | 2021 | |
| Medtronic, INC. | $86.02 | 2023 | Mazor X System |
| Boston Scientific Corporation | $59.39 | 2025 | Wavewriter Alpha Prime 16 |
| Abbvie INC. | $18.65 | 2022 | |
| Ceribell, INC. | $15.45 | 2023 | Ceribell Rapid Response Eeg |
| Abbott Laboratories | $14.41 | 2019 | |
| Alexion Pharmaceuticals, INC. | $13.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.